Efficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura.

ABSTRACT:

SUBMITTER: Weisinger J 

PROVIDER: S-EPMC11705199 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature